Pfizer and Allergan look like the latest pharmaceutical companies to start early dealmaking talks , according to reports, in a deal which may, if it goes ahead, mark the zenith of the industry's megamerger trend.
The man with the golden touch.
After pulling out of a bid for AstraZeneca last year amid controversy on both sides of the Atlantic, US group Pfizer has been suggested as a potential predator for another UK pharmaceutical institution - GlaxoSmithKline.
Pascal Soriot, the chief executive of the drugmaker AstraZeneca, saw his pay rise by 5% to £3.5m in 2014 after he helped resist a takeover approach from its US rival Pfizer.
The federal court has dismissed a case against Pfizer Australia which claimed the pharmaceutical giant misused its market power and engaged in anti-competitive conduct in the way it supplied one of its blockbuster drugs to pharmacists.
GlaxoSmithKline has once again topped a league table that measures the major pharmaceuticals companies’ efforts in enabling people in developing countries to get the drugs they need, while rivals Pfizer and Sanofi have slipped down the rankings.
The AstraZeneca boss Pascal Soriot has hinted that another takeover approach from its US rival Pfizer has become less likely after a US clampdown on tax inversions, as the British drugmaker upped its 2014 sales and profit forecasts for the second time this year.
Bankers on both sides of the Atlantic have lost the chance to collect "jackpot" fees of £345m following the collapse of US drugs giant Pfizer's £69bn bid for its British rival AstraZeneca.
Here is some excellent advice from an old hand to the directors of AstraZeneca should Pfizer, as expected, get serious about bidding and increase its current £48-a-share offer: don't be swayed by the views of investment bankers chasing success fees; don't judge bid premiums based on a two- to three-year view; and remember you have responsibilities beyond price.
Pfizer has said it will keep its promises about keeping high-skill jobs and manufacturing in Britain before the US company's boss faces his first grilling by MPs on the proposed takeover of AstraZeneca.
Leeds United manager Marcelo Bielsa could not contain his delight at beating Middlesbrough.
Mikel Arteta's Arsenal might need a new creative kingpin - could Red Bull Salzburg's Dominik Szoboszlai be the next hero of the Emirates?
Ryan Kent was reunited with the Rangers manager Steven Gerrard at Ibrox 18 months ago.
Liverpool beat West Ham United 3-2 on Monday night.
Rangers beat Braga 1-0 in the Europa League on Wednesday.
Tottenham Hotspur youngster Harvey White is regarded as one of the best young players breaking through at the club.
Jurgen Klopp's Liverpool side managed to complete one of the greatest Champions League come backs last season.
Liverpool boss Jurgen Klopp can sign Timo Werner for £50 million this summer, with a release clause built into his RB Leipzig contract.
The Tottenham Hotspur loanee is continuing to struggle on loan.
Steven Gerrard’s Glasgow Rangers have won in the Europa League this evening.
The largest pharmaceuticals merger in history, between Pfizer and Allergan, could be abandoned after the US government took fresh steps to clamp down on tax avoidance deals.
AstraZeneca is splashing out hundreds of millions of pounds on buying the lung drug portfolio of Japan’s Takeda and deepening its presence in China, despite the country’s recent slowdown.
Less than two months ago, the finance ministers of the G20 gathered for a celebratory dinner in Peru to mark agreement on a “once-in-a-century” package of reforms to combat tax avoidance by multinational corporations that is costing governments up to $240bn a year.